Clinical Trial

Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients

Study acronym: ALRCVO-MP
Recruiting
View on ClinicalTrials.gov →
Summary
Sickle cell disease is a chronic disease characterized by multiple vaso-occlusive complications. The basic treatment for patients with a vaso-occlusive crisis (VOC) is based on adequate hydration, oxygen therapy and pain control. Loco Regional Anesthesia (LRA) is one of the major treatments in resuscitation anesthesia for both anesthesia and analgesia. LRA allows effective and almost immediate pain control by blocking nerve afferents in a given area. LRA could decrease the inflammatory response during crises and accelerate resolution of the crisis.
Trial Details
NCT Number NCT07001189
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions Sickle Cell, Sickle Cell Disease, Vaso-Occlusive Crises
Enrollment 34 participants
Start Date 2025-02-05
Primary Completion 2027-02-05 (estimated)
Study Completion 2027-02-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-03